Van Dalen R, Vree T B, Baars I M
Pharm Weekbl Sci. 1987 Apr 24;9(2):98-103. doi: 10.1007/BF01960743.
A pharmacokinetic study after a single dose of ceftriaxone, cefoxitin, cefuroxime and ceftazidime was performed to investigate the influence of protein binding and severity of disease on the renal elimination. In intensive-care patients drug-protein binding was substantially less compared to that in volunteers and patients with less complicated diseases. This did not result in increased elimination but, due to increased apparent volumes of distribution, prolonged half-life times were observed. Consequently, in patients with complicated disease states a dosage regimen should be based on pharmacokinetic studies performed in a similar patient group.
进行了单剂量头孢曲松、头孢西丁、头孢呋辛和头孢他啶的药代动力学研究,以调查蛋白质结合和疾病严重程度对肾脏排泄的影响。与志愿者和病情较轻的患者相比,重症监护患者的药物-蛋白质结合明显较少。这并未导致排泄增加,但由于分布表观容积增加,观察到半衰期延长。因此,对于患有复杂疾病状态的患者,给药方案应基于在类似患者群体中进行的药代动力学研究。